Sort   by:  
 Page size 
UnknownInhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.
Not available
S-EPMC9320910 | biostudies-literature
UnknownIn silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigations.
Not available
S-EPMC11293250 | biostudies-literature
UnknownLinagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches.
Not available
S-EPMC9948186 | biostudies-literature
UnknownInhibition of MARK4 by serotonin as an attractive therapeutic approach to combat Alzheimer's disease and neuroinflammation.
Not available
S-EPMC9215163 | biostudies-literature
UnknownPlasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.
Not available
S-EPMC3431182 | biostudies-literature
UnknownAdapting evidence-based clinical practice guidelines for people with attention deficit hyperactivity disorder in Saudi Arabia: process and outputs of a national initiative.
Not available
S-EPMC7871371 | biostudies-literature
UnknownAntitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).
Not available
S-EPMC5941615 | biostudies-literature
UnknownRosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).
Not available
S-EPMC2797969 | biostudies-literature
UnknownMutations in the Key Autophagy Tethering Factor EPG5 Link Neurodevelopmental and Neurodegenerative Disorders Including Early-Onset Parkinsonism.
Not available
S-EPMC12577676 | biostudies-literature
UnknownAssociation of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes.
Not available
S-EPMC8722802 | biostudies-literature
Sort   by:  
 Page size